GEPHARDT GROUP GOVERNMENT AFFAIRS for TEVA PHARMACEUTICALS USA, INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
21st Century Cures; S. 484 and H.R. 1353, PATIENTS Act of 2015; Innovation for Healthier Americans
Foreign entity interest: Teva Pharmaceuticals Industries Ltd., as the indirect parent of Teva Pharmaceuticals USA, Inc., has an interest in the issues listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL MESSMER | — |
| JANICE O'CONNELL | — |
Labor Issues/Antitrust/Workplace LBR
Teva's acquisition of Mylan
Foreign entity interest: Teva Pharmaceuticals Industries Ltd., as the indirect parent of Teva Pharmaceuticals USA, Inc., has an interest in the issues listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL MESSMER | — |
| JANICE O'CONNELL | — |
Alcohol and Drug Abuse ALC
21st Century Cures; S. 484 and H.R. 1353, PATIENTS Act of 2015; Innovation for Healthier Americans
Foreign entity interest: Teva Pharmaceuticals Industries Ltd., as the indirect parent of Teva Pharmaceuticals USA, Inc., has an interest in the issues listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL MESSMER | — |
| JANICE O'CONNELL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.